Back to Search Start Over

MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.

Authors :
Lucy Liu
Gaboriaud, Nicolas
Vougogianopoulou, Konstantina
Yan Tian
Jun Wu
Wei Wen
Skaltsounis, Leandros
Jove, Richard
Source :
Cancer Biology & Therapy. Feb2014, Vol. 15 Issue 2, p1-7. 7p.
Publication Year :
2014

Details

Language :
English
ISSN :
15384047
Volume :
15
Issue :
2
Database :
Academic Search Index
Journal :
Cancer Biology & Therapy
Publication Type :
Academic Journal
Accession number :
94364253
Full Text :
https://doi.org/10.4161/cbt.26721